The caspase-11 noncanonical inflammasome is activated in response to lipopolysaccharide (LPS), a highly immunogenic endotoxin present in the outer membrane of Gram-negative bacteria. and is closely associated with the pathogenesis of sepsis. Activatio...
The caspase-11 noncanonical inflammasome is activated in response to lipopolysaccharide (LPS), a highly immunogenic endotoxin present in the outer membrane of Gram-negative bacteria. and is closely associated with the pathogenesis of sepsis. Activation of caspase-11 induces gasdermin D (GSDMD) cleavage, pyroptosis, and the release of IL-1β and IL-18, collectively driving severe inflammatory responses such as acute lethal sepsis. However, the intrinsic cellular mechanisms that negatively regulate this pathway remain poorly understood.
In this study, we investigated whether Lys116 tri-methylation of calmodulin (CaM)—a major calcium-binding regulatory protein—modulates caspase-11 noncanonical inflammasome responses. We found that expression of calmodulin-lysine N-methyltransferase (CAMKMT) was markedly reduced during caspase-11 activation, leading to decreased CaM Lys116 tri-methylation and suppression of CaM-dependent signaling, including the CaMKK2–CaMKIV phosphorylation axis. Overexpression of CAMKMT restored CaM trimethylation, normalized CaM-dependent phosphorylation signaling, and significantly inhibited caspase-11 and GSDMD cleavage, pyroptosis, and IL-1β and IL-18 production.
Furthermore, introduction of a trimethylation-defective CaM mutant (K116A), in which Lys116 was substituted with alanine, abolished the anti-inflammatory effects, demonstrating that CaM Lys116 tri-methylation is essential for caspase-11 noncanonical inflammasome regulation. In an in vivo acute lethal sepsis model,
CaM WT significantly improved survival, reduced sepsis scores, and attenuated systemic inflammation, whereas CaM K116A further increased inflammatory responses
Collectively, our findings identify CaM Lys116 tri-methylation as a critical regulator of caspase-11 noncanonical inflammasome activation and highlight the CaM Lys116 methylation as a potential therapeutic target for acute inflammatory diseases.